Article Text

Download PDFPDF
Veterinary Medicines
IFAH highlights barriers to innovation on medicines

Statistics from

EUROPEAN regulatory processes are a significant obstacle to innovation when it comes to developing new veterinary medicines, according to a recent report from the International Federation for Animal Health (IFAH).

The IFAH represents the manufacturers of veterinary medicines. Its report, Benchmarking the Competitiveness of the Global Animal Health Industry, presents the results of a survey of animal health companies conducted last year, and is the fourth in a series of benchmarking reports dating back to 1996. The survey, which is conducted every five years, examines the interactions between industry and regulatory systems, particularly the animal health industry's ability to be competitive and innovative. The 2011 survey was the second to include companies in Australia, Canada and Japan as well as Europe and the USA, and the data presented are based on responses to 65 questionnaires and 72 in-depth interviews. The European section of the report analyses data from 16 companies and makes comparisons with the other …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.